Insider Transactions in Q4 2021 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Indirect |
20,047
-3.95%
|
$902,115
$45.46 P/Share
|
|
Dec 29
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Indirect |
32,104
-11.11%
|
$1,380,472
$43.88 P/Share
|
|
Dec 28
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Indirect |
10,980
-3.66%
|
$483,120
$44.37 P/Share
|
|
Dec 06
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,476
-1.9%
|
$61,992
$42.52 P/Share
|
|
Dec 06
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-1.08%
|
$420,000
$42.14 P/Share
|
|
Dec 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.29%
|
$824,985
$45.35 P/Share
|
|
Nov 10
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.65%
|
$86,632
$52.9 P/Share
|
|
Nov 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-1.06%
|
$520,000
$52.94 P/Share
|
|
Nov 01
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.29%
|
$83,300
$50.05 P/Share
|
|
Nov 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.43%
|
$898,317
$49.24 P/Share
|
|
Oct 04
2021
|
Marc Tessier Lavigne Director |
BUY
Bona fide gift
|
Indirect |
300,000
+50.0%
|
-
|
|
Oct 04
2021
|
Marc Tessier Lavigne Director |
SELL
Bona fide gift
|
Direct |
300,000
-11.79%
|
-
|
|
Oct 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-1.04%
|
$500,000
$50.64 P/Share
|
|
Oct 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.28%
|
$916,650
$50.27 P/Share
|